MRPL39 and nasopharyngeal carcinoma: Although, our findings provide insights into the value of lnc-MRPL39-2:1 as a promising therapeutic target against NPC, further studies are required to develop precise strategies targeting lnc-MRPL39-2:1 signaling and clarify the role of lnc-MRPL39-2:1 in other cancers.